Compare HURA & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HURA | EPM |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 137.2M |
| IPO Year | 2010 | 1996 |
| Metric | HURA | EPM |
|---|---|---|
| Price | $2.13 | $3.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $9.50 | $4.83 |
| AVG Volume (30 Days) | 264.2K | ★ 541.0K |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 10.08% |
| EPS Growth | ★ 47.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $43,229,621.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $3.19 |
| 52 Week High | $3.43 | $5.70 |
| Indicator | HURA | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 40.67 |
| Support Level | $1.88 | $3.22 |
| Resistance Level | $2.20 | $3.71 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 6.78 | 34.11 |
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.